A RELIABLE screening test for malignant disease has long been sought but of the many tests devised, using a wide variety of techniques, none is sufficiently reliable for routine use.
In attempts to produce such a screening test the trypsin inhibitor activity of serum has often been used and many methods have been introduced to measure this inhibitor activity (Peacock and Sherry, 1952; Homer, Katchman and Zipf, 1963) . Most of the methods have used one or other of a variety of substrates which have been capable of hydrolysis by a wide range of proteolytic enzymes rather than by trypsin specifically. Nardi (1958) described a technique for the estimation of serum trypsin using the substrate benzoyl-l-arginine amide hydrochloride (BAA). His findings could not be confirmed (Kemp, 1959, unpublished; Babson, Williams and Phillips, 1962) but in the course of the work a method of estimating the trypsin inhibitor activity of serum has been devised using BAA as a substrate. Although at first it was thought that BAA was specifically hydrolysed by trypsin, Nardi (1959, personal communication) later recognised that it may also be hydrolysed by the plant enzyme papain and by plasmin (fibrinolysin), the effect of the latter in his determination being considered negligible. Plasmin may be produced by the trypsin activation of plasminogen and the specificity of any test for serum trypsin or serum trypsin inhibitor activity using BAA may therefore be reduced. The evidence concerning activation of plasminogen by trypsin is conflicting but if trypsin is present in excess any plasmin formed is rapidly destroyed (Astrup, 1956 (6) Tungstic acid solution.-To 2*5 ml. of (4) add 3 0 ml. of (5) 
H.). Sera
Serum was obtained, as far as possible without selection, from hospital inpatients and from out-patients attending this laboratory. The staff of the laboratory and other apparently healthy persons form the group of normal controls. 5 ml. of blood was taken in a clean, dry syringe, transferred to a test tube and allowed to clot. Serum was separated within 3 hours of collection and stored at 4C. overnight, a 1 in 8 dilution in distilled water being made immediately before use.
METHOD 0 05 ml. of the buffered substrate is added to each of four chemically clean test tubes. Trypsin solution (0.05 ml.) is added to the standard, test and control tubes, 0*05 ml. serum (1: 8 dilution) to the test tube, and 0 05 ml. distilled water to the standard and blank tubes.
After shaking, the tubes are incubated for 60 minutes at 370 C. in a water bath. Diluted serum (0.05 ml.) and trypsin solution (0.05 ml.) are then added to the control and blank tubes respectively and 0 55 ml. tungstic acid solution to each tube. All tubes are shaken, allowed to stand for 15 minutes and centrifuged.
To 0*5 ml. of each supernatant 2-5 ml. of gum ghatti solution are added. After mixing the tubes are left until any slight turbidity disappears and 0.5 ml. Nessler's reagent is then added and the tubes again mixed.
The final mixture is read in a spectrophotometer at 440 m/t, the blank being used to zero. Calculation:
T O x 40X 005 X = mg. trypsin inhibited by 1 0 ml. serum.
i.e. C x 64 = mg. trypsin inhibited by 1 0 ml. serum.
RESULTS
Serum trypsin inhibitor activity (STIA) has been estimated in 1043 individuals and the clinical conditions and numbers of persons as well as the values for the mean, standard deviation and range are detailed in Table I . The cases have also been divided into three main groups, normal, malignant and miscellaneous non-malignant conditions, and the distribution of values in each of these three groups is shown in Fig. 1 . The narrow range of the "normal" group contrasts sharply with the wide distribution of values in the other two groups.
In previous work of this nature (Cliffton, 1950) it was noted that certain conditions, particularly pregnancy, acute inflammation and post-operative states, are frequently associated with a high STIA: this was confirmed in the present series and a high STIA was also noted in many cases of myocardial infarction (Table I ). The distribution of the values for these four conditions are separately shown in Fig. 2 .
The cases in these four conditions have been removed from the miscellaneous non-malignant group and the distribution of values of the remaining cases is shown in Fig. 3 . An intermediate-range was calculated for the group of miscellaneous nonmalignant hospital cases, excluding those conditions known to have a high STIA (pregnancy, acute inflammation, post-operative states, myocardial infarction) (Fig. 3) Values of 2 -4 and above were considered abnormal.
DISCUSSION
In assessing the merit of any screening test for the detection of malignantdisease it has been stated that the test should give a positive (abnormal) result in at least 90 per cent of cases of malignancy and give not more than 5 per cent of " false " positive results (Dunn and Greenhouse, 1950) and the figures in this. series have therefore been calculated as percentages (Table II) . This lack of specificity does not mean, however, that the test is without a certain limited value. In " normal " individuals the values are low and no false positive result has been found. Further, in the miscellaneous non-malignant group of hospital cases, provided that certain relatively readily recognised conditions (pregnancy, acute inflammation, post-operative states and myocardial infarction) are excluded, the false positive results are less than 5 per cent.
A normal value does not exclude the presence of malignant disease. Conversely, however, a consistently abnormal STIA merits detailed investigation and is usually indicative of some form of disease.
SUMMARY
Serum trypsin inhibitor activity has been estimated in 1043 individuals by a method using benzoyl-l-arginine amide hydrochloride (BAA) which is a more specific substrate for tryptic hydrolysis than those previously used for this purpose. The method is unsatisfactory as a general screening test for malignant disease but a high value, in the absence of certain conditions (acute inflammation, post-operative states, myocardial infarction and pregnancy), indicates the need for further investigation of the patient.
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